De verborgen gevaren van vaccinaties - WantToKnow.nl

The study was done by CoMeD, Inc. (a non-profit) through a grant from the Brenen
Hornstein Autism Reserch & Education Foundation and the non-profit Institute of Chronic
Illnesses, Inc. Attribution was also given to the Genetic Centers of america.
CoMD, Inc. And BHARE recommend parents and health care providers have children with
ASD diagnosis tested by urinary porphyrin profile analysis (UPPA). More information is
available at CoMeD’s websiteMercury-freeDrugs.org, including free information on ordering
UPPA tests as well as papers validating those tests.
Resources:
1 – A Mitochondrial Dysfunction, Impaired Oxidative-Reduction Activity, Degeneration, and
Death in Human Neuronal and Fetal Cells Induced by low-level Exposure to Thimerosal and
Other Metal Compounds http://www.informaworld.com/smpp/co...
2 – Natural News “Thimerosal” articles: http://www.naturalnews.com/GoogleSe...
3 – Press Release from CoMeD on study: http://mercury-freedrugs.org/docs/0...
Bovenstaand artikel is niet het eerste dat wijst op de link tussen thimerosal en autisme.
Thimerosal werd en wordt gebruikt in vaccins tegen kinderziekten en dus ook in de
zogenaamde MMR-prik (measles, mumps and rubella). In Nederland is dit de BMR-prik.
Hieronder volgt daarom een aantal publicaties die dit verband al eerder onder de aandacht
brachten:
The MMR (or Measles) Vaccine and Autism:
Oleske, J. "Elevated rubeola [measles] titers in autistic children." Abstract
presented by D. Zecca and Dr. Graffino at an NIH meeting (September 23, 1997). As
quoted by Richard Gallup in "Autism and autoimmunity."
www.chiroweb.com/archives/18/14/10.html (April 15, 2002.)
Fudenberg, H.H. "Dialysable lymphocyte extract (DlyE) in infantile onset
autism: a pilot study." Biotherapy 1996; 9:143-147.
Gupta, S. "Immunology and immunologic treatment of autism." Proceedings
of the National Autism Association, Chicago 1996: 455-460.
Wakefield, A.J., et al. "Ileal-lymphoid-nodular hyperplasia, non-specific colitis,
and pervasive developmental disorder in children." Lancet 1998; 351:637-641.
Yazbak, F.E. "Autism: Is there a vaccine connection? Part I. Vaccination after
delivery." 1999. www.garynull.com/documents/autism99b.htm
Yazbak, F.E. "Autism: Is there a vaccine connection? Part II. Vaccination
around pregnancy." 1999. www.garynull.com/documents/autism99b2.htm
Yazbak, F.E. "Autism: Is there a vaccine connection? Part III. Vaccination
around pregnancy, the sequel." 2000. www.garynull.com/documents/autism99b3.htm
"Autism: Present Challenges, Future Needs -- Why the Increased Rates?"
Government Reform Committee Hearing, Washington, DC. (April 6, 2000.)
"Autism: Why the Increased Rates? A One-Year Update." Government
Reform Committee Hearing, Washington, DC. (April 25-26, 2001.)
"The Autism Epidemic: Is the NIH and CDC Response Adequate?"
Government Reform Committee Hearing, Washington, DC. (April 18, 2002.)
37